Kimon Chatzistamatiou
Overview
Explore the profile of Kimon Chatzistamatiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsolakidis D, Kyziridis D, Panoskaltsis T, Kalakonas A, Theodoulidis V, Chatzistamatiou K, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075751
Hyperthermic intraperitoneal chemotherapy (HIPEC) was revealed as a promising adjunct to cytoreductive surgery (CRS) in the treatment of advanced epithelial ovarian cancer (EOC). This review evaluated the impact HIPEC had...
2.
Tsolakidis D, Zouzoulas D, Tzitzis P, Sofianou I, Theodoulidis V, Chatzistamatiou K, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941788
Douglasectomy is defined as the removal of the pelvic peritoneum of the entire pouch of Douglas. In presumed FIGO stage I ovarian cancer, isolated microscopic cancer cells might disseminate from...
3.
Tsolakidis D, Zouzoulas D, Sofianou I, Karalis T, Chatzistamatiou K, Theodoulidis V, et al.
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336462
: The new molecular classification of endometrial cancer continuously changes the management of the disease in everyday clinical practice. Recently, FIGO released a new staging system for endometrial cancer, which...
4.
Zouzoulas D, Tsolakidis D, Tzitzis P, Chatzistamatiou K, Theodoulidis V, Sofianou I, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791269
BRCA mutation and homologous recombination deficiency (HRD) are the criteria for the administration of PARP inhibitor (PARPi) maintenance therapy. It is known that PARPi efficacy is related to platinum sensitivity...
5.
Zouzoulas D, Tsolakidis D, Tzitzis P, Sofianou I, Chatzistamatiou K, Theodoulidis V, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38610943
(1) Background: Neoadjuvant chemotherapy followed by interval debulking surgery is used in the treatment of advanced ovarian cancer. However, no tool can safely predict if complete cytoreduction after 3-4 cycles...
6.
Sofou E, Gkoliou G, Pechlivanis N, Pasentsis K, Chatzistamatiou K, Psomopoulos F, et al.
Front Microbiol
. 2023 Dec;
14:1292230.
PMID: 38098662
Increasing evidence supports a role for the vaginal microbiome (VM) in the severity of HPV infection and its potential link to cervical intraepithelial neoplasia. However, a lot remains unclear regarding...
7.
Chatzistamatiou K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, Pasentsis K, Skenderi A, et al.
Gynecol Oncol
. 2021 Jul;
162(3):560-568.
PMID: 34210517
Objective: To identify the optimal strategy for the triage of women who test high-risk (hr) HPV positive on self-collected cervicovaginal samples. Methods: This is a diagnostic accuracy sub-analysis of the...
8.
Chatzistamatiou K, Vrekoussis T, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, Pasentsis K, et al.
J Womens Health (Larchmt)
. 2020 Aug;
29(11):1447-1456.
PMID: 32757997
Human papillomavirus (HPV)-DNA testing combined with self-sampling could increase cervical cancer screening effectiveness, utilizing a sensitive screening modality and an easy sampling method with minimal pain or discomfort. Self-sampling acceptability,...
9.
Nasioutziki M, Chatzistamatiou K, Loufopoulos P, Vavoulidis E, Tsampazis N, Pratilas G, et al.
Infect Agent Cancer
. 2020 Apr;
15:22.
PMID: 32318115
Background: Infection with human papillomaviruses (HPVs) can cause benign and malignant tumours in the anogenital tract and the oropharynx both in men and women. The aim of the presented study...
10.
Skroumpelos A, Agorastos T, Constantinidis T, Chatzistamatiou K, Kyriopoulos J
PLoS One
. 2019 Dec;
14(12):e0226335.
PMID: 31830114
Background: HPV test appears to be more effective in cervical cancer (CC) screening. However, the decision of its adoption as a primary screening method by substituting the established cytology lies...